May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 07, 2025

FDA Approves Low-Dose Chlorthalidone Tablet

The FDA has approved HemiClor, a 12.5-mg chlorthalidone tablet, providing patients with a low-dose option.

Conexiant

May 06, 2025

FDA Approves TAVR Platform for Asymptomatic AS

The FDA has approved the SAPIEN 3 TAVR platform for patients with asymptomatic severe aortic stenosis based on data from the EARLY TAVR trial.

Conexiant

May 06, 2025

New SCIA Flap Option Shows Safe Results

A new breast reconstruction technique using the superficial branch of the SCIA flap showed safe outcomes in 4 women, offering an alternative to DIEP flaps with less abdominal trauma.

Conexiant

May 05, 2025

Missed Screenings? Anal Cancer Surge in Women

Rates rising 4.3% in white women over 65, outpacing increases in other demographics.

Conexiant

May 05, 2025

Men With Panic Disorder Use More Substances, Study 

Researchers analyzed over 10,000 adults and found that individuals with panic disorder reported more severe alcohol and tobacco use, especially among men, with no significant differences across racial groups.

Conexiant

May 02, 2025

Psychotherapy, Family Tied to Better Outcomes

In a large meta-analysis, researchers identified the most effective components of collaborative care for treating depression in primary care.

Conexiant

May 02, 2025

Digital Monitoring App Improves Asthma Quality of Life in Trial

A digital asthma symptom monitoring app modestly improved patient-reported quality of life, with greater benefits seen in younger adults and those with low self-management skills.

Conexiant

May 02, 2025

Personalizing Eating Disorder Care Advances, Study

A global research team reviewed current treatments for eating disorders and found that while personalization is seen as essential by patients and clinicians, most approaches still lack strong supporting evidence.

Conexiant